Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952817 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Indoleamine 2,3-Dioxygenase 2 (IDO2) (AA 274-303), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 274-303, C-Term
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients.
Induction of indoleamine 2, 3-dioxygenase by death receptor activation contributes to apoptosis of melanoma cells via mitochondrial damage-dependent ROS accumulation.
Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target.
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.
Huttunen R, Syrjänen J, Aittoniemi J, Oja SS, Raitala A, Laine J, Pertovaara M, Vuento R, Huhtala H, Hurme M
Shock (Augusta, Ga.) 2010 Feb;33(2):149-54
Shock (Augusta, Ga.) 2010 Feb;33(2):149-54
Induction of indoleamine 2, 3-dioxygenase by death receptor activation contributes to apoptosis of melanoma cells via mitochondrial damage-dependent ROS accumulation.
Cetindere T, Nambiar S, Santourlidis S, Essmann F, Hassan M
Cellular signalling 2010 Feb;22(2):197-211
Cellular signalling 2010 Feb;22(2):197-211
Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target.
Witkiewicz AK, Costantino CL, Metz R, Muller AJ, Prendergast GC, Yeo CJ, Brody JR
Journal of the American College of Surgeons 2009 May;208(5):781-7; discussion 787-9
Journal of the American College of Surgeons 2009 May;208(5):781-7; discussion 787-9
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.
Ball HJ, Sanchez-Perez A, Weiser S, Austin CJ, Astelbauer F, Miu J, McQuillan JA, Stocker R, Jermiin LS, Hunt NH
Gene 2007 Jul 1;396(1):203-13
Gene 2007 Jul 1;396(1):203-13
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.
Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC
Cancer research 2007 Aug 1;67(15):7082-7
Cancer research 2007 Aug 1;67(15):7082-7
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
